Home
News
Create
Screeners
Insights
Sudeep Pharma
593.
90
-15.25
(-2.50%)
Market Cap
₹6,708.02 Cr
PE Ratio
49.52
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-2.50%
1M
-2.10%
6M
-23.28%
1Y
-23.28%
5Y
-23.28%
View Company Insights
Latest news about Sudeep Pharma
Sudeep Pharma Subsidiary Acquires Gujarat Land Rights for ₹20.97 Crores Manufacturing Facility
10 days ago
Sudeep Pharma Limited's wholly owned subsidiary, Sudeep Advanced Materials Private Limited, has acquired leasehold rights to 80,980.19 square meters of land in Dahej, Gujarat for ₹20.97 crores. The land, purchased from DCM Shriram Fine Chemicals Limited, will be used to establish a commercial manufacturing facility for battery-grade iron phosphate. The transaction is subject to regulatory approvals and represents the company's strategic expansion into battery materials manufacturing.
Sudeep Pharma Limited Updates CIN and Company Status Following Stock Exchange Listing
Jan 16, 2026
Sudeep Pharma Submits Q2FY26 Earnings Call Audio Recording to Stock Exchanges
Dec 21, 2025
Sudeep Pharma Q2 Results: EBITDA Drops 12.6% to ₹55.5 Cr, Margin Shrinks
Dec 19, 2025
Sudeep Pharma Completes Q2FY26 Results Publication in Newspapers
Dec 15, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation